BEAM
Beam Therapeutics Inc.
Beam Therapeutics Inc. (BEAM) has 15 SEC Form 4 filings (27 transaction rows) in the rolling window, disclosed by 6 distinct insiders. Most recent filing: Jul 2, 2026.
The most active filer is CEO Evans John M. with 5 filings. Insiders have net sold $14.3M over the trailing 6 months.
- Industry:Biotechnology
- CEO:John Evans
- Employees:522
- HQ:Cambridge, MA, US
- IPO:2020-02-06
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$14.3M
reported sales (SEC code S)
Unique Insiders
6
in the rolling window
Market Cap
$2.6B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Chief Medical Officer | Sale | 373 | $13K | Jul 2 | SEC ↗ | |
| CEO | Sale | 25,000 | $887K | Jul 1 | SEC ↗ | |
| CEO | Sale | 25,000 | $858K | Jul 1 | SEC ↗ | |
FMR LLCFirst filing | See Remark 1 | Sale | 33,372 | $1.2M | Jun 29 | SEC ↗ |
FMR LLCFirst filing | See Remark 1 | Sale | 251,488 | $8.9M | Jun 29 | SEC ↗ |
Simon AmyFirst filing | Chief Medical Officer | Sale | 6,700 | $165K | Apr 6 | SEC ↗ |
Ciaramella GiuseppeFirst filing | President | Sale | 11,810 | $290K | Apr 6 | SEC ↗ |
Bellon ChristineFirst filing | Chief Legal Officer | Sale | 5,956 | $146K | Apr 6 | SEC ↗ |
| CEO | Sale | 30,078 | $739K | Apr 6 | SEC ↗ | |
Cavanagh Bethany JFirst filing | SVP, Finance and Treasurer | Sale | 3,242 | $80K | Apr 6 | SEC ↗ |
Evans John M.First filing | CEO | Sale | 25,000 | $559K | Apr 1 | SEC ↗ |
Evans John M.First filing | CEO | Sale | 25,000 | $569K | Apr 1 | SEC ↗ |
Related companies
Beam Therapeutics Inc. is in the Healthcare sector.